Scientist develop gilded flu test

December 2, 2013
Prof David Russell from UEA (L) and Prof Rob Field from JIC (R)

Researchers on the Norwich Research Park have patented a quick, simple dipstick flu test using sugar labelled with gold.

Quick diagnosis of flu is important because vaccination and need to be administered to patients within 48 hours of infection to prevent new pandemics arising.

"We are now looking for a diagnostics company to help us bring it to market," said Professor Rob Field from the John Innes Centre.

He and Professor David Russell from the University of East Anglia found that a gold solution changes colour in the presence of the . And the colour it changes to differs according to the strain of flu.

Results published in Organic & Biomolecular Chemistry show that can be used to detect the human influenza virus X31 (H3N2) within 30 minutes and to distinguish between human and avian influenza.

Prof Field explains that 90% of human infections use carbohydrate recognition to bind with targets in the body. The sensor is a suspension of sugars tagged with . If the flu virus is present, it will attach to a sugar, pulling particles closer together. Human and avian flu have a preference for different sugar chains resulting in a colour change visible to the naked eye.

"The same basic principles can be applied wherever rapid detection is required from detecting superbugs in hospitals to biohazards such as ricin," said Professor Field.

The researchers have already developed a carbohydrate-based sensor to detect cholera in contaminated water supplies.

"Our technique based on gold nanoparticles is much faster than current methods of detection," said Professor Russell from UEA.

Explore further: Severe flu complications for cancer patients

Related Stories

Severe flu complications for cancer patients

November 25, 2013

It is often noted that very young people and the elderly are most at-risk for experiencing flu-related complications, and one expert at the University of Alabama at Birmingham says people with weakened immune systems due ...

Recommended for you

Ebola virus mutations may help it evade drug treatment

September 11, 2015

Genetic mutations called "escape variants" in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of U.S. Army scientists and collaborators. Their findings, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.